39 results
424B5
STOK
Stoke Therapeutics Inc
28 Mar 24
Prospectus supplement for primary offering
5:15pm
federal government shutdown, on our business, financial condition and operations, including on our expenses, supply chain, strategic partners, research
424B5
STOK
Stoke Therapeutics Inc
26 Mar 24
Prospectus supplement for primary offering
4:47pm
, financial condition and operations, including on our expenses, supply chain, strategic partners, research and development costs, clinical trials and employees
8-K
EX-99.1
mx400isl1pypnx9arq
10 Jan 22
Entry into a Material Definitive Agreement
7:01am
8-K
EX-99.1
fr0du532
10 May 21
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
7:05am
8-K
EX-99.1
v6m1ujh0gbm7q
9 Mar 21
Stoke Therapeutics Reports Full Year 2020 Financial Results and Provides Business Updates
7:30am
8-K
EX-99.1
md2cyatb
5 Feb 21
Regulation FD Disclosure
4:27pm
8-K
EX-99.1
4yxi76qwb3eqf5gm
11 Jan 21
Results of Operations and Financial Condition
8:01am